Skip to content

Measurement of Serum Potassium Rate During Accidental Hypothermia.

A Comparative Study of Serum Potassium Rate Between Peripheral and Central Venous Sample Collection in Patients With Hypothermia Related Cardiac Arrest

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03096561
Acronym
Kai+
Enrollment
12
Registered
2017-03-30
Start date
2016-11-14
Completion date
2019-07-31
Last updated
2017-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accidental Hypothermia, Cardiac Arrest, Hyperkalemia

Brief summary

Serum Potassium Rate (PR) is a key indicator for medical management of patients with accidental hypothermia particularly for hypothermia related cardiac arrest (CA). Experts recommend a cut-off value for PR of 12 mmol/l for all hypothermic victims and 8 mmol/l for avalanche casualties. Any patient presenting a PR lower than the cut-off value should be considered for Extracorporeal Rewarming. This therapeutic strategy is vital for patient survival. However, there is no consensus about what type of vessels should be punctured in order to obtain an accurate potassium rate and what type of measurement technics should be used to measure this potassium rate. The investigators hypothesize that potassium rate in these patients will differ by 1 mmol/l in blood samples collected from a peripheral vein in contrast to a central vein. The investigators study is a prospective observational, multicentre study.

Interventions

DIAGNOSTIC_TESTblood draw from three different vessels

Patient in cardiac-arrest and cold exposure, diagnostic test: blood draw from three different vessels (central vein, artery, peripheral vein) and measuring of PR

Sponsors

University Grenoble Alps
CollaboratorOTHER
Centre Hospitalier Universitaire Vaudois
CollaboratorOTHER
Emergency Department, Hospital of Valais, Sion
CollaboratorUNKNOWN
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hypothermia related cardiac arrest * Age \> 18 years * Core temperature \< 30° C measured in oesophagus at hospital admission

Exclusion criteria

* Age \< 18 years * Known condition of pregnancy or breastfeeding women * Evidence of trauma-related cardiac arrest * Cardiac arrest in which reanimation is not justified (frozen body, final stadium of an incurable disease, advance health care directive)

Design outcomes

Primary

MeasureTime frameDescription
Comparison of potassium rate in central venous blood and blood from a peripheral vein (measured in mmol/l)24 hoursComparison of PR in central venous blood and blood from a peripheral vein (measured in mmol/l)

Secondary

MeasureTime frameDescription
Comparison of potassium rate in venous and arterial blood (measured in mmol/l)24 hoursComparison of potassium rate in venous and arterial blood (measured in mmol/l)
Comparison of potassium rate from laboratory analysis and at bedside via blood gas analyser (measured in mmol/l)24 hoursComparison of potassium rate from laboratory analysis and at bedside via blood gas analyser (measured in mmol/l)
Comparison of the time difference between laboratory analysis and blood gas analyzer at bed side (measured in minutes)24 hoursComparison of the time difference between laboratory analysis and blood gas analyzer at bed side (measured in minutes)
Survival and neurological outcome as measured by the Cerebral Performance Category Scale3 monthsSurvival and neurological outcome as measured by the Cerebral Performance Category Scale
Study of biological parameters to calculate the Strong Ion Gap (measured in mEq/l) according to the Stewart Approach24 hours1. For each sample, the apparent strong ion difference (SIDa) will be calculated as SIDa =(Na+ +K+ +Ca2+ +Mg2+)-(Cl- +Lac-) 2. The amount of weak plasma acid (A-) will be calculated as: A- = \[Alb\] × (0.123 × pH - 0.631) + \[PO4\] × (0.309 × pH - 0.469) 3. The effective strong ion difference (SIDe) will be calculated as: SIDe = 1000 × 2.46 × 10-11 × PaCO2/(10-pH) + \[A-\] To quantify unmeasured charges, the SIG will be calculated as: SIG = SIDa - SIDe

Countries

Switzerland

Contacts

Primary ContactMarc Blancher, MD
MBlancher@chu-grenoble.fr+33 (0) 476634266
Backup ContactSarah K Buse
sarah@drbuse.de+49 (0) 15201911437

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026